Alzheimers Flashcards

1
Q

how are amyloid diseases characterised?

A

Naturally occuring protein unfolds, misfolds, aggregates and collects into fibrous plaques
Disrupted ACh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe amyloid plaque structure

A

Formed from β-sheet protein and look similar in an x-ray beam
Form a cross every 4.7Å and 10Å at right angles, caused by parallel β-strands running at right angles
These pack into the same fibre

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is systematic amyloid disease?

A

Body producing excessive amounts of amyloid deposits in different tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What causes acute phase proteins to be produced?

A

Persistent chronic inflammation and builds and produces amyloid deposits in the kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How can dialysis lead to iatrogenic disease?

A

β2 microglobulin is a component of MHC Class I and builds up in organs and joints. Therefore β2 microglobulin was removed from dialysis mixture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe alzheimer’s disease

A

Accounts for 60-70% dementia
First symptoms are short term memory
Apathy, leading to withdrawal
After diagnosis, life expectancy is 3-9 years
Some genetic origins but incidence increases with age
Parts of the brain associated with language and memory die

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe Aβ

A

40-42 residues made of APP.
TM and extracellular folded domain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How can alzheimers be treated?

A

Cholinesterase inhibitors- slow impairment of cholinergic neurons
NMDA glutamateric receptor agonist- prevents overstimulation of synapses.
Increasing α-secretase activity to decrease αβ
γ-secretase cleaves notch, so has effects all over the body unless targetted to the brain. Targetting the APP docking site, regulatory site or change where it cuts the C-terminus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How can NSAIDs be used to treat alzheimer’s?

A

Act as modulators and make γ-secretase change from αB(1-42) to αB(1-40)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What antibodies have been used to treat alzheimers?

A

Adceumab recognises amyloid aggregates and not Aβ monomers
No harmful effect, may work with high doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What problems are associated with alzheimers drugs

A

Having multiple drug targets
Breaking down fibres to oligomers is toxic and makes it worse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How can the amyloid cascade be slowed?

A

Reduce cholesterol with statins
Tau kinases and tau aggregation inhibited so microtubules don’t stabilise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why can alzheimer’s be considered type III diabetes?

A

Typre II produces inflammation and vascular damage to the brain, causing vascular dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What effect does Apo have on alzheimers?

A

ApoE2 is protective
ApoE4 is a risk factor. We don’t know why. May do something bad like make γ-secretase cut APP to make Aβ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe parkinson’s disease

A

Loss of physical and mental function
Shaking hands, rigidity in posture
Age related, more common in males
Affects dopamine
intrinsically disordered α-synuclein is the amyloid protein and collects in Lewy bodies in neurons
Symptoms apparent when 80% cells are dead

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the genetic factors of parkinson’s disease

A

α-synuclein gene which organises presynaptic vesicles
LRRK2 gene involved in neurite outgrowth
TMEM230 which encodes a TM protein of secretory/recycling vesicles

17
Q

What environmental factors are there to parkinson’s

A

Pesticides, head injury, metals

18
Q

Why are intrinsically disordered proteins more likely to form aggregates

A

They do not need to unfold first so have a lower energy barrier

19
Q

Describe kuru

A

Women ate brains of dead relatives, so kuru mainly spread in women
2% mortality
Almost eradicated due to can of cannibalism
Resistant allele G127V spread due to selective pressure. Caused a selective sweep

20
Q

How does Aβ form?

A

APP is converted by presenilin to Aβ
Apolipoprotein E4 impairs Aβ clearance from the brain
The Ab oligomers phosphorylate tau which is neurotoxic

21
Q

Describe the Ab variants

A

Aβ42 and 43 self-aggregate ajd Aβ40 is amyloidogenic

22
Q

How might alzheimer’s be associated with Down’s syndrome?

A

APP gene is on chromosome 21 so individuals with down’s syndrome may produce too much Aβ lifelong, making them very susceptible to Alzheimer’s

23
Q

What boosts protein aggregation?

A

Lipid bilayer interactions
pH changes in endosomes or lysosomes
Mutation/truncation of a polypeptide

24
Q

How can IAPP damage lipid bilayers?

A

IAPP fibres elongate
β-sheet rich seed elongates, disrupting the bilayer
Accelarates primary nucleation of α-synuclein fibres

25
Q

Describe secondary nucleation

A

Fibre fragmentation increases templating fibre ends which precursors are added to.
Fibre fragmentation increases endosomesand lysosomes taking up amyloid fibres
Local oligomer con increases

26
Q

How can Aβ cause neurotoxicity?

A

Aβ can bind to mouse PirB or human ortholog LilrB2
This causes a signal cascade in neurons, hijacking the actin cytoskeleton and causing synaptic loss. Happens via receptor-ligand interaction

27
Q

Why can Alzheimer’s e be considered type 3 diabetes?

A

Refer to word document

28
Q

How can obesity be linked to alzheimer’s

A

Obesity is a risk factor for alzheimer’s and dementia as adipocytes secrete proteins, hormones and cytokines
Inflammation from this may cause vascular changes in the brain

29
Q

How can nerve growth factor (NGF) be used as an alzheimer’s treatment?

A

Loss of NGF may contribute to loss of cholinergic neurons in AD
Crinical trials successful, e.g fibroblasts containing NGF-encoding viral vector implanted into AD patient forebrains

30
Q

How is ApoE4 an alzheimer’s risk factor?

A

Cleavage of ApoE4 may give a truncated ApoE that impairs mitochondrial energy production and disrupt the cytoskeleton

31
Q

How does lithium treat alzheimers?

A

It prevents tau phosphorylation

32
Q

How can concentration of APP, tau and ApoE4 be lowered?

A

Small molecules or RNAi